Overview
Hiroshi Kobayashi practices practicing medicine in Tokyo, Japan.
Mr. Kobayashi is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Mucopolysaccharidoses (MPS), Fabry Disease, Pompe Disease, and Bone Marrow Transplant.
He is actively involved in clinical research, co-authoring 44 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hiroshi Kobayashi
Is Hiroshi Kobayashi a top-rated expert for Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)?
MediFind is an objective health platform that identifies experts based on real-world data. Hiroshi Kobayashi is classified as an Elite expert for Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hiroshi Kobayashi participate in research or clinical trials?
Yes. Hiroshi Kobayashi has published 44 articles and abstracts on conditions like Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). You can view a list of Hiroshi Kobayashi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
- Distinguished
- Mucopolysaccharidoses (MPS)Mr. Kobayashi isDistinguished. Learn about Mucopolysaccharidoses (MPS).
- Advanced
- Fabry DiseaseMr. Kobayashi isAdvanced. Learn about Fabry Disease.
- GM1 GangliosidosisMr. Kobayashi isAdvanced. Learn about GM1 Gangliosidosis.
- Pompe DiseaseMr. Kobayashi isAdvanced. Learn about Pompe Disease.
- Experienced
- Adrenoleukodystrophy (ALD)Mr. Kobayashi isExperienced. Learn about Adrenoleukodystrophy (ALD).
- Bone Marrow TransplantMr. Kobayashi isExperienced. Learn about Bone Marrow Transplant.
- CardiomyopathyMr. Kobayashi isExperienced. Learn about Cardiomyopathy.
- Farber LipogranulomatosisMr. Kobayashi isExperienced. Learn about Farber Lipogranulomatosis.
- GangliosidosisMr. Kobayashi isExperienced. Learn about Gangliosidosis.
- Hypertrophic Cardiomyopathy (HCM)Mr. Kobayashi isExperienced. Learn about Hypertrophic Cardiomyopathy (HCM).
- Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome)
- Niemann-Pick DiseaseMr. Kobayashi isExperienced. Learn about Niemann-Pick Disease.